Pre-Emptive Analgesia for Elective Maxillofacial Surgery Using 0.25% Bupivacaine

The efficacy of 0.25% bupivacaine as a pre-emptive analgesic agent was evaluated in a prospective case control study - a group of patients undergoing elective orthognathic surgery against a matched control group. Bupivacaine was administered as a series of nerve blocks prior to the incision for the...

Full description

Bibliographic Details
Main Authors: Radhika Krishnan, S Shivananda, Uma Raman
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2008-01-01
Series:Indian Journal of Anaesthesia
Subjects:
Online Access:http://www.ijaweb.org/article.asp?issn=0019-5049;year=2008;volume=52;issue=5;spage=556;epage=556;aulast=Krishnan